1. Australian Public Assessment Report for Pralatrexate, August 2013, https://www.tga.gov.au/auspar/auspar-pralatrexa.
2. Safety and efficacy of pralatrexate in the treatment of patients with relapsed or refractory peripheral T-cell lymphoma;Marchi;Ther. Adv. Hematol.,2012
3. Stability testing of new drug substances and products (step4);ICH Q1A(R2),2003
4. Impurities in new drug substances (step4);ICH Q3A(R2),2006
5. Impurities in new drug products (step4);ICH Q3A(R2),2006